Cambridge Heart, Inc. Release: Wellpoint To Cover Microvolt T-Wave Alternans Testing

Published: Nov 13, 2006

BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH) today announced that WellPoint/Anthem has revised its Coverage Policy Bulletin (MED.00041) on Microvolt T Wave Alternans agreeing to make it a covered benefit for its beneficiaries in California and 13 other states. The revised policy now states:

Back to news